tm logo
RCB
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 25 Sep 2023

Last Applicant/ Owned by

1220 Blalock Rd., Suite 300

Houston

TX

77055

Serial Number

97205537 filed on 06th Jan 2022

Registration Number

N/A

Correspondent Address

Naira Simmons

Naira Simmons

32 School Ln

Scarsdale NY 10583

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RCB

Medical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development Read More

Classification Information


Class [045]
Personal & Legal & Social Services


Providing a website via a global computer network featuring supportive personal stories on the subjects of health, cancer, cancer recovery and survival

Class [044]
Medical, Beauty & Agricultural Services


Medical testing, prediction and assessment for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; Providing medical, assessment and prediction information to medical professionals in the field of cancer and disease classification; Providing medical information, assessment and prediction to medical professionals on sensitivities of cancers to hormones and/or hormone therapies

Class [042]
Computer & Software Services & Scientific Services


Medical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development of pharmaceuticals for the assessment and prediction of effectiveness of treatment of age-related diseases and cancer; Assessment and predictions of medical diagnosis and treatment of cancer; Providing information about medical research, predictions and assessments in the field of cancer

Class [010]
Medical Instrument Products


Medical apparatus or device for assessing the recurrence of cancer; Medical diagnostic apparatus for assessing and predicting recurrence of cancer cells incorporating recorded operating system software; Medical nanites for assessing and predicting the recurrence of cancer; Medical nanorobots for assessing and predicting recurrence of cancer; Medical microrobots for assessing and predicting recurrence of cancer after treatment

Class [005]
Pharmaceutical Products


Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Protein arrays for diagnosing cancer; Biological preparations for the assessment of recurrence of cancer; Pharmaceutical products for the assessment of a treatment of viral and infectious diseases, for the assessment of treatment of cancer; assessment for anti-cancer preparations; assessment of protein arrays for diagnosing cancer

Mark Details


Serial Number

No 97205537

Mark Type

No Service Mark

Attorney Docket Number

No 17947.T002US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
25th Sep 2023ABANDONMENT - NO USE STATEMENT FILED
25th Sep 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
02th Feb 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
31st Jan 2023SOU TEAS EXTENSION RECEIVED
31st Jan 2023SOU EXTENSION 1 FILED
31st Jan 2023SOU EXTENSION 1 GRANTED
30th Jan 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30th Jan 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30th Jan 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
23rd Aug 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT